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We recently showed that mutations in the CNGA3 gene encoding the a-subunit of the cone photoreceptor cGMP-
gated channel cause autosomal recessive complete achromatopsia linked to chromosome 2q11. We now report the
results of a first comprehensive screening for CNGA3 mutations in a cohort of 258 additional independent families
with hereditary cone photoreceptor disorders. CNGA3 mutations were detected not only in patients with the
complete form of achromatopsia but also in incomplete achromats with residual cone photoreceptor function and
(rarely) in patients with evidence for severe progressive cone dystrophy. In total, mutations were identified in 53
independent families comprising 38 new CNGA3 mutations, in addition to the 8 mutations reported elsewhere.
Apparently, both mutant alleles were identified in 47 families, including 16 families with presumed homozygous
mutations and 31 families with two heterozygous mutations. Single heterozygous mutations were identified in six
additional families. The majority of all known CNGA3 mutations (39/46) are amino acid substitutions compared
with only four stop-codon mutations, two 1-bp insertions and one 3-bp in-frame deletion. The missense mutations
mostly affect amino acids conserved among the members of the cyclic nucleotide gated (CNG) channel family and
cluster at the cytoplasmic face of transmembrane domains (TM) S1 and S2, in TM S4, and in the cGMP-binding
domain. Several mutations were identified recurrently (e.g., R277C, R283W, R436W, and F547L). These four
mutations account for 41.8% of all detected mutant CNGA3 alleles. Haplotype analysis suggests that the R436W
and F547L mutant alleles have multiple origins, whereas we found evidence that the R283W alleles, which are
particularly frequent among patients from Scandinavia and northern Italy, have a common origin.
Introduction
Human daylight and color vision relies on the presence
and functional integrity of three types of retinal pho-
toreceptors—the cones sensitive to short (blue), middle
(green), and long (red) wavelengths—which are char-
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acterized by the expression of specific visual pigments
(cone opsins). Color discrimination depends on the dif-
ferential excitation of the cone pigments by light stimuli
of specific wavelengths and the appropriate processing
of the postreceptor signals. Functional loss or alterations
in the spectral properties of one type of cone photore-
ceptors—as caused by mutations, deletions, or structural
rearrangements of one of the opsin genes—may result
in selective color-vision deficiencies, such as the common
forms of X-linked red-green color blindness (protan and
deutan defects) or the less frequent autosomal dominant
inherited blue-yellow (tritan) deficiency (Nathans et al.
1986; Weitz et al. 1992; for a review, see Sharpe et al.
1999). More-general forms of color blindness involve
Wissinger et al.: CNGA3 Mutations in Cone Photoreceptor Disorders 723
the degeneration, dysfunction, or absence of two or more
types of cone photoreceptors, as in patients with achro-
matopsia or cone dystrophies.
Whereas patients with cone dystrophy may secondarily
develop total color blindness following the progressive
degeneration of cone photoreceptors, the term “achro-
matopsia” denotes a group of congenital and stationary
retinal disorders with normal rod function but with ab-
sent or limited cone photoreceptor function associated
with photophobia and nystagmus. Complete achroma-
topsia (also referred to as “rod monochromacy” or “total
color blindness”) is defined by the absence of measurable
cone photoreceptor function. Patients are totally color
blind, visual acuity is !0.2, there is severe photophobia
under daylight conditions, and nystagmus is evident
within the first month after birth. Complete achroma-
topsia is inherited as an autosomal recessive trait. Its
prevalence has been estimated to be1:30,000 (Francois
1961; Sharpe and Nordby 1990; Sharpe et al. 1999).
Residual cone function—either measured by ERG re-
cordings and/or assessed on the basis of performance on
color tests—essentially distinguishes incomplete from
complete achromatopsia. The severity of symptoms (i.e.,
visual-acuity loss, photophobia) is generally less pro-
nounced than with complete achromats. However, there
is considerable variability in the clinical manifestation
among incomplete achromats. In particular, color testing
performance varies markedly—ranging from nearly nor-
mal performance, with specific axes of confusion, to neg-
ligible color-matching ability—and depends on the type
of test used (Ja¨ger 1953; Goodman et al. 1963; Neuhann
et al. 1978; Ja¨gle et al. 2001). Most cases of incomplete
achromatopsia are sporadic or occur among siblings,
consistent with an autosomal recessive mode of inheri-
tance. The molecular basis of incomplete achromatop-
sia is largely unknown. One notable exception is blue
cone monochromacy (BCM [MIM 303700]), a particular
form of incomplete achromatopsia that is caused by mu-
tations in a solitary red or red-green hybrid opsin gene,
simultaneous mutations in both red and green opsin
genes, or deletions within the adjacent locus control re-
gion (Nathans et al. 1993). Acceptance of blue filter
glasses for improving contrast vision, color discrimina-
tion along the blue-yellow axis, and X-linked inheritance
distinguish BCM from other forms of achromatopsia
(Hansen 1979; Zrenner et al. 1988; Andreasson and
Tornqvist 1991; Sharpe et al. 1999).
By means of linkage analysis, two loci for complete
achromatopsia, ACHM2 (MIM 216900) and ACHM3
(MIM 262300), have been identified on chromosomes
2q11 and 8q21, respectively (Arbour et al. 1997; Wis-
singer et al. 1998; Milunsky et al. 1999; Winick et al.
1999). Subsequently, we showed that mutations in the
CNGA3 gene (MIM 600053) cause complete achro-
matopsia in families that show linkage to the ACHM2
locus (Kohl et al. 1998), and, more recently, we and
others were able to identify the CNGB3 gene (MIM
605080) that is mutated in families segregating disease
with the ACHM3 locus (Kohl et al. 2000; Sundin et al.
2000). CNGA3 and CNGB3 encode the a- and putative
b-subunits of the cone photoreceptor cGMP-gated chan-
nel (cone CNG channel), which represents a crucial com-
ponent of the cone phototransduction cascade. Whereas
high levels of cGMP in the photoreceptor outer segment
keep the CNG channel open for cation influx in the dark,
light stimulation results in a decrease of the cGMP level
and, subsequently, in the closure of the CNG channel.
This closure shuts off the steady inward current and thus
generates a membrane hyperpolarization signal that de-
creases the glutamate release at the photoreceptor syn-
apse (Mu¨ller and Kaupp 1998). When the importance of
the CNG channel in phototransduction is considered, the
phenotype of achromatopsia can be well explained as a
result of mutations in the CNGA3 or CNGB3 gene. Fur-
thermore, it implies that the same CNG channel is com-
mon to all three types of cone photoreceptors. Analysis
of the homologous CNGA3 knockout–mouse model
shows complete absence of physiologically measurable
cone function, a decrease in the number of cones in the
retina, and morphological abnormalities of the remaining
cones (Biel et al. 1999). These results accord with the
four histological examinations that have been made of
human purported achromat eyes, although the extent of
loss in cone number and their regional distribution varied
considerably, and at least one of the cases was more
consistent with cone dystrophy (Larsen 1921; Harrison
et al. 1960; Falls et al. 1965; Glickstein and Heath 1975;
Sharpe and Norby 1990). Variability in histological pre-
sentation may reflect heterogeneity in the genetic etiology
of achromatopsia and/or inclusion of cases with complete
and incomplete achromatopsia.
In our initial article on CNGA3 mutations, we de-
scribed eight different missense mutations segregating
in five families with complete achromatopsia (Kohl et
al. 1998). Since then, we have completed a large-scale
screening of the CNGA3 gene, which now provides
deeper insight into this causal relationship, as well as
into a number of related issues: (i) the prevalence of
CNGA3 mutations in achromatopsia, (ii) the allelic het-
erogeneity of CNGA3 mutations, (iii) the recurrence
rate and origin of common CNGA3 mutations, and (iv)
the spectrum of cone photoreceptor disorders caused by
CNGA3 mutations. Although our original families with
CNGA3 mutations have been categorized with com-
plete achromatopsia, we hypothesized that CNGA3 al-
leles might exist that do not completely abolish cone
function and thus may result in incomplete achroma-
topsia. Given that mutations in the homologous gene
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in rod photoreceptors cause retinitis pigmentosa, a pro-
gressive form of retinal dystrophy (Dryja et al. 1995),
and that degenerative processes have been noticed in
some patients with BCM and incomplete achromatopsia
(Goodman et al. 1963; Neuhann et al. 1978; Ayyagari
et al. 1999), we also included patients diagnosed with
progressive cone dystrophy in this study.
Subjects, Material, and Methods
Patients and Clinical Examination
Patients were examined in several clinical centers in
Germany, The Netherlands, Denmark, Italy, Sweden,
France, Turkey, and the United States. The largest num-
bers of patients were of apparent German (∼37%), Dutch
(∼18%), Danish (∼12%), and Italian (∼12%) origins.
Clinical diagnosis was based on disease history, routine
ophthalmological examination, and specialized visual
function testing, such as color vision tests, scotopic and
photopic electroretinography (ERG), and dark-adapted
psychophysics. In addition, a patients’ questionnaire was
used which addressed the family history, subjective views
about major visual complaints, onset and course of the
disease, a history or presence of additional nonretinal
diseases (namely heart or kidney diseases or male infer-
tility), impairments of other sensory systems (namely
hearing, balance, taste, and smell) and the presence of
sleep disorders or impairment of day-night rhythms.
The index patient sample comprises 215 independent
patients (including those five described elsewhere by
Kohl et al. [1998]) with a diagnosis of congenital achro-
matopsia, either complete or incomplete, and 48 inde-
pendent patients with cone dystrophy. Criteria used in
this study for diagnosis of the three different types of
cone disorders were as follows:
Complete achromatopsia.—These patients have visual
acuity !0.2, nystagmus or a history of nystagmus in
childhood, severe photophobia, no measurable response
to conventionally performed light-adapted (photopic) or
30-Hz flicker cone ERGs but normal rod function, com-
plete inability to perform color-discrimination tasks, and
a normal fundus.
Incomplete achromatopsia.—These patients have re-
duced visual acuity and may or may not have nystagmus
or photophobia. Whereas the degree of cone dysfunction
can vary considerably, rod function is not impaired. Pa-
tients have residual cone ERG responses and/or color-
matching capabilities which distinguish such patients
from those with complete achromatopsia. The fundus is
normal.
Cone dystrophy.—These patients have the visual func-
tion findings of achromats, but there is evidence of pro-
gressive loss of vision (sometimes including the rods)
and fundus abnormalities, such as macular degenerative
changes or peripheral retinopathy. Venous blood was col-
lected from the patients and available family members
after informed consent was given, and total genomic DNA
was extracted according to standard procedures.
Mutation Screening
Exons and flanking intron sequences of the CNGA3
gene were amplified by PCR from total genomic DNA
(Kohl et al. 1998) and were subjected to direct DNA
sequencing or SSCP analysis. Initially, mutation screen-
ing was done by sequence analysis of both strands for
all coding exons (exons 1–7) and flanking intron/un-
translated sequences. In later stages of the project, we
adopted a more practical screening protocol: (i) sequence
analysis of exon 7, (ii) sequence or SSCP analysis of
exons 5 and 6, and (iii) sequence analysis of all remain-
ing exons, including exons 2b and 0 in those patients
in whom only a single heterozygous mutation had been
identified to that point.
For SSCP analysis, PCR products were separated on
10% polyacrylamide gels (with or without 10% glycerol)
in 1# TBE at 4C or room temperature and were silver
stained. For direct sequencing, PCR products were pu-
rified by Centricon-100 ultrafiltration (Amicon) or Qia-
quick columns (Qiagen) and were subjected to DNA se-
quencing employing the AmpliTaq FS Dye Terminator or,
in later stages, the BigDye Terminator Chemistry (PE Ap-
plied Biosystems). Sequences were separated on an ABI
373A or an ABI 377 DNA sequencer (PE Applied Bio-
systems), were analyzed manually and independently by
two experimenters and were assembled with the SeqMan
program (DNASTAR).
Cosegregation analysis and exclusion of the mutations
in control subjects ( ) was done either by PCR/np 100
RFLP or SSCP analysis. Primer sequences and RFLP
assay conditions are available from the authors upon
request.
Polymorphisms and Haplotype Analysis
Genotyping of microsatellite markers D2S2187,
D2S2311, and CNGA3-STR was performed by PCR
amplification from genomic DNA through use of fluo-
rescence-labeled primers, separation of the products on
5% polyacrylamide/8 M urea gels on an ABI 373 DNA
sequencer (PE Applied Biosystems), and analysis with
the Genescan software program, as described elsewhere
(Wissinger et al. 1998). Intragenic SNP genotyping was
done by PCR/RFLP analysis: 72TrC results in the loss
of a BglII site; 102-16ArG results in the loss of an NsiI
site after amplification with mismatch-containing (MM)
primer CNGA3-PMNsiI (5′-TTG AAA TCA ATT CTG
CTT GAT GC-3′ [mismatch underlined]); 21546TrG
results in the gain of a BglI site after amplification with
MM primer CNGA3-PMBglI (5′-TTA TTA TGG CCT
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GGG GGC CAC TGT-3′); and 215151TrC results in
the gain of a Cac8I site after amplification with MM
primer CNGA3-PMCac8I (5′-ACA TCT GAC CCA
AGA GGA AAT TGC TC-3′). Disease haplotypes were
reconstructed on the basis of the allele segregation within
individual families. In addition, nondisease haplotypes
were reconstructed to serve as controls for allele and
haplotype frequencies among the study population. In
some individuals with noninformative results for SNPs
21546TrG or 215151TrC, the phase could be re-
solved by double digests with BglI and Cac8I.
Haplotypes that could not be reconstructed unequiv-
ocally—either because of noninformative allele segre-
gation of markers or because samples from critical fam-
ily members were not available—were considered as
conforming with the common haplotype for this mu-
tation if one of the observed alleles matched the common
allele.
RNA Isolation, RT-PCR, and RACE
Total RNA was isolated from human donor retinas
and the human retinoblastoma cell line WERI-Rb1 by
use of Trizol reagent (Life Technologies). Three-micro-
gram aliquots of total RNA were reverse transcribed into
single-stranded cDNA with AMV reverse transcriptase
and oligo(dT) adaptor primers (RNA PCR Kit, Takara).
cDNA aliquots were used to amplify overlapping seg-
ments of the 5′ portion of CNGA3. For 5′ RACE, ∼20
ng of Marathon-Ready Human Retinal cDNA (Clon-
tech) was subjected to nested PCR amplifications with
adaptor primers and CNGA3 cDNA primers. RT-PCR
and RACE products were gel purified and were cloned
with the TA Cloning System (Invitrogen). The isolated
plasmid DNA was sequenced with standard pUC/M13
forward and reverse primers.
Isolation of PAC Clones
PAC clones were isolated by hybridization against a
high-density filter of a human chromosome 2 library
(Gingrich et al. 1996) or by PCR screening of pools of
the RPCI1 library (Ioannou and de Jong 1996) provided
by the U.K. Human Genome Mapping Project (HGMP)
resource center. PAC DNA was isolated by standard al-
kaline lysis protocols, and the insert size was determined
by PFGE separation of NotI-digested PAC DNA. STS
content mapping was performed with 500 pg of PAC
DNA and PCRs limited to 23–25 thermal cycles. PAC
DNA was subcloned into the partially filled-in XhoI site
of pBluescript SKII vectors by limited digestion of PAC
DNA with Bsp143I, partial fill-in of the 5′ protruding
ends, and isolation of 8–15-kb fragments from prepar-
ative agarose gels.
Database Sequences and Amino Acid–Sequence
Alignment
The GenBank sequences used to construct an align-
ment of CNG channels’ protein sequences and to analyze
the evolutionary conservation of corresponding amino
acid positions (table 1) were: the CNG channel a-sub-
units of human cone photoreceptors (accession number
AF065314), of mouse cone photoreceptors (AJ243933),
of chicken cone photoreceptors (X89598), of human rod
photoreceptors (S42457), and of bovine olfactory epi-
thelium (X55010); the Drosophila melanogaster CNG
channel (X89601); and the Caenorhabditis elegans tax4
CNG channel (D89601). Sequences were aligned us-
ing the CLUSTAL algorithm implemented in the MEG-
ALIGN program of the DNASTAR software package.
Probability values for the equal distribution of muta-
tions (i.e., evolutionarily conserved amino acid positions
vs. nonconserved positions) were calculated using the x2
test.
Results
Genomic Structure and Additional Exons of the
CNGA3 Gene
We recently reported the entire coding sequence of the
human CNGA3 gene and its genomic structure, com-
posed of seven exons (Wissinger et al. 1997). Using
RACE and RT-PCR, we were able to extend theCNGA3
cDNA by an additional 168 bp of 5′ untranslated se-
quence. This sequence is encoded by an extra exon, des-
ignated “exon 0” and localized ∼24 kb upstream of exon
1 (fig. 1). Exon 0 and the downstream intron sequence
are enriched for -CG- dinucleotides, suggesting that the
newly identified sequence is in close proximity to the
actual transcription initiation site. In addition, we found
a 38-bp-long sequence segment overlapping with the ul-
timate 5′ end of the human cDNA to be almost com-
pletely identical to the 5′ end of the orthologous bovine
cDNA (fig. 1b). The evolutionary conservation of this
sequence implies that it may bear some specific func-
tion—for example, in transcription regulation.
During our efforts to identify additional 5′ sequences,
we recurrently observed a retinal splicing variant that
includes an additional 165 bp of coding sequence be-
tween exons 2 and 3. This additional exon, designated
“exon 2b,” extends the low conserved aminoterminal
part of the CNGA3 polypeptide by 55 amino acids (fig.
1c). No other known CNG channel contains sequences
homologous to those encoded by exon 2b, and database
searches provided no significant similarities with other
proteins. Thus, the functional relevance of this sequence
and the splice variant itself remain unclear.
On the basis of our sequence analysis of PAC clones
isolated for the CNGA3 gene and the database sequence
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Figure 1 Genomic structure of the CNGA3 gene and sequences of newly identified exons. A, Schematic genomic map of the CNGA3
gene covered by two finished BAC sequences (AC013751 and AC010134) and additional PAC clones isolated from the RPCI1 library and a
chromosome 2–specific LLNL library (AI-2-D12). The CNGA3 gene is composed of nine exons, including the newly identified exons 0 and 2b.
The locations of STR and SNP markers used for haplotype analysis are indicated at the top. B, Nucleotide sequence of exons 0 and 1 and
flanking sequences. cDNA sequences are boxed and are shown in uppercase letters, whereas flanking 5′ genomic and intron sequences are given
in lowercase letters. Note that the extent of exon 0 was deduced from the longest 5′ RACE clone. A 38-bp segment conserved between the
human CNGA3 gene and the 5′ UTR of the orthologous bovine cDNA is highlighted by a gray box. C, Nucleotide sequence of the alternatively
spliced exon 2b and flanking intron sequences. The exon sequence is boxed and is shown in uppercase letters, with the deduced in-frame amino
acid sequence shown above it as single-letter codes.
of BAC clone RP11-629A22 (GenBank accession number
AC027241), the entire CNGA3 gene covers ∼53 kb of
genomic sequence (fig. 1a). The markers D2S2311 and
D2S2187 (located on the overlapping BAC clone RP11-
127K18 [GenBank accession number AC010134]) were
identified ∼1.6 kb and ∼90 kb downstream of the poly-
adenylation site, respectively, and thus represent the in-
dexed genetic markers closest to the CNGA3 gene (fig.
1a). Another CA-dinucleotide repeat was found ∼27 kb
upstream of the 5′-terminal exon 0 and was used to de-
velop an additional polymorphic dinucleotide marker,
CNGA3-STR, for segregation analysis and haplotype
construction (see below).
Mutation Screening
Mutation screening was performed in a total sample
of 258 independent index patients. CNGA3 mutations
were identified in 53 of those patients. Notably, muta-
tions were not confined to the group of patients with
Table 1
CNGA3 Mutations
ALTERATION OF
NUCLEOTIDE SEQUENCEa
ALTERATION
POLYPEPTIDEb,c
NO. OF
CHROMOSOMESd
EVOLUTIONARY CONSERVATIONe
HC MC CC HR BO DM CE
Exon 2:
148insG G49fs 1
Exon 5:
485ArT D162V 1 D D D D D D D
488CrT P163L* 3 P P P P P P P
542ArG Y181C 2 Y Y Y Y Y Y Y
544ArT N182Y 1 N N N N N N N
556CrT L186F 1 L L L V L V V
Exon 6:
572GrA C191Y 3 C C C C C V V
580GrA E194K 1 E E E E D E D
667CrT R223W 3 R R R R R H R
671CrG T224R 1 T T T T T E M
Exon 7:
778GrA D260N 1 D D D D D D D
800GrA G267D 1 G G G G G P I
829CrT R277C 9 R R R R R R R
830GrA R277H 2 R R R R R R R
847CrT R283W* 19 R R R R R R R
848GrA R283Q* 2 R R R R R R R
872CrG T291R* 1 T T T T T T T
934-936delATC I312del 3 I I I I I V/L/If I
947GrA W316X 1
1021TrC S341P 1 S S S N T N N
1106CrG T369S 1 T T T T T T V
1114CrT P372S 3 P P P P P P P
1139TrC F380S 1 F F F F F F F
1217TrC M406T 1 M M M M M M M
1228CrT R410W* 3 R R R R R R R
1279CrT R427C 3 R R R R R R R
1306CrT R436W 6 R R R R K R R
1320GrA W440X 1
1350insG V451fs 1
1412ArG N471S 1 N N N N N Q Q
1454ArT D485V 1 D D D D D D D
1529GrC C510S 2 C C C C C C C
1538GrA G513E 1 G G G G G G G
1547GrA G516E 1 G G G G G G G
1565TrC I522T 1 I I I I I V V
1574GrA G525D 1 G G G G G G G
1585GrA V529M* 1 V V V V V V V
1609CrT Q537X 1
1641CrA F547L* 12 F F F F F F F
1669GrA G557R* 2 G G G G G G G
1688GrA R563H 3 R R R R R R R
1694CrT T565M 2 T T T T T T T
1706GrA R569H 1 R R R K R R R
1718ArG Y573C 1 Y Y Y Y Y Y Y
1777GrA E593K 1 E E E D D E D
1963CrT Q655X 1
a Sequence position within the CNGA3 cDNA, with 1 denoting the first nucleotide of the ATG start codon.
b fs p frameshift.
c Mutations reported by Kohl et al. (1998) are marked by asterisks (*).
d Number of observed mutant chromosomes.
e Corresponding amino acid residues in the sequences of the following CNG gated channels: HC p human
cone; MC p murine cone; CC p chicken cone; HR p human rod; BO p bovine olfactory epithelium; DM p
Drosophila melanogaster; and CE p Caenorhabditis elegans-tax4 (see Subjects, Material, and Methods).
f Alternatively aligned amino acids.
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Figure 2 Location of the mutations with respect to the proposed topological model of the CNGA3 polypeptide including the six trans-
membrane helices (S1–S6), the ion pore, and the cGMP-binding domain (modified according to Zagotta and Siegelbaum [1996]).
complete achromatopsia but were also found in patients
with incomplete forms of achromatopsia and even in a
few patients diagnosed with cone dystrophy (see below).
Apparently homozygous mutations were found in 16
patients, and another 31 patients carried two heterozy-
gous mutations. However, homozygosity could be mim-
icked by the presence of heterozygous deletions, and two
heterozygous mutations might be present in cis. To ex-
clude these possibilities, segregation analysis of the mu-
tations was performed within the respective families. True
homozygosity could be established in all cases in which
both parents could be genotyped (12/16). Similarly, for
the cases with two heterozygous mutations, we could ex-
perimentally verify their independent inheritance (allel-
ism) in all cases in which samples from unaffected family
members were available (23/31). Moreover, the segrega-
tion patterns of mutations within families were consistent
with respect to the affection status and confirmed the
presence of both mutant alleles in 16 other affected family
members (not shown).
Only single heterozygous mutations were identified in
an additional six index patients. In these patients, all
exons of the CNGA3 gene (including exons 0 and 2b)
were sequenced, and large structural alterations of the
CNGA3 gene were ruled out by Southern blot hybrid-
ization in selected patients.
We identified a total of 38 new CNGA3 mutations, in
addition to the 8 mutations reported elsewhere (table 1;
Kohl et al. 1998). In the combined sample of known
CNGA3 mutations, the vast majority (39/46) represent
amino acid substitutions, compared with only 4 stop-co-
don mutations, 2 single-codon insertions, and 1 single-
codon in-frame deletion. Among the single-base–substi-
tution mutations (missense plus stop-codon mutations),
there were 35 transitions and 8 transversions, and a pre-
ponderance of guanine and cytosine nucleotides (33/43)
affected by mutations. We observed the typical increased
incidence of mutations in -CG- dinucleotides (10/43). This
accounts at least in part for the high frequency of sub-
stitutions at arginine codons (10 of 39 missense muta-
tions; table 1).
The distribution of mutations in CNGA3 is biased
towards the central and terminal segments of the gene.
Only a single mutation, 148insG (G49fs), was observed
within the first six exons (exons 0, 1, 2, 2b, 3, and 4);
all other mutations are located in the three terminal ex-
ons (exons 5, 6, and 7). With the exception of the early
frameshift mutation, G49fs, and the terminal stop-codon
mutation, Q655X, all remaining mutations are concen-
trated between amino acid positions 162 and 593, a
region that accounts for less than two-thirds of the cod-
ing sequence (fig. 2). Thus the mutations are mainly
confined to the functionally and structurally important
central parts of the CNGA3 polypeptide, including the
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six transmembrane helices (S1–S6), the ion pore, and the
cGMP-binding domain. An apparent clustering of mu-
tations can be seen at the terminus of transmembrane
helix S1 (amino acid positions 181–194), transmem-
brane helix S4 (amino acid positions 277–291) and parts
of the cGMP-binding domain (amino acid positions
510–529 and 557–573). Excluding the frameshift and
stop codon mutations, 40 amino acid positions in the
CNGA3 gene are affected by mutation. All these amino
acids are at least conserved among cone CNG channel
a-subunits, and 27 of them are even conserved among
the various CNG channels in vertebrate photoreceptors
and the olfactory epithelium, as well as in the CNG
channels in Drosophila and Caenorhabditis (table 1).
The high degree of evolutionary conservation presum-
ably reflects the functional importance of the mutated
amino acid positions. If the overall conservation of these
sequences is taken into account, the difference in the
distribution of mutations between evolutionarily con-
served amino acid positions and non-conserved positions
is highly significant ( ).P ! .0001
Recurrent CNGA3 Mutations: Frequency, Geographic
Distribution, and Haplotypes
Including the patients reported previously (Kohl et al.
1998), we identified a total of 110 of the 116 expected
mutant alleles among our 58 independent patients with
CNGA3 mutations. Several mutations were found recur-
rently in different patients (table 1). The most prevalent
mutations were R283W (19 mutant chromosomes),
F547L (12 mutant chromosomes), R277C (9 mutant
chromosomes), and R436W (6 mutant chromosomes).
Together, these four mutations account for 46 of the 110
identified ACHM2 chromosomes (41.8%). Whereas the
high prevalence of the R283W mutation is due, in part,
to homozygosity for this mutation (seven patients), the
F547L, R277C, and R436W mutations were mostly ob-
served in patients with compound-heterozygous muta-
tions. The geographic distribution of these most-fre-
quent recurrent mutations is quite different: although
140% (24/58) of patients with CNGA3 mutations were
of German origin, only 2 of the 12 patients with the
R283W mutation were from Germany and the remain-
der were from Norway, Sweden, Denmark, and northern
Italy. In contrast, all but one patient with the R436W
mutation were of German origin. The most widespread
distribution was observed for the F547L mutation,
which was found in German, Dutch, Italian, Turkish,
and Pakistani families.
To investigate the history of recurrent mutations, we
reconstructed mutation-linked haplotypes, including
three closely linked simple tandem repeat (STR) markers
(CNGA3-STR, D2S2311, and D2S2187) and four intra-
genic single-nucleotide polymorphisms (SNPs) covering,
altogether, a physical distance of ∼170 kb around the
CNGA3 gene (fig. 1a).
We found evidence that, in some instances, recurrent
mutations are of common origin, whereas, in others, they
probably originate from independent mutation events.
R410W- and R563H-linked haplotypes that differ from
each other at several marker loci provide support for the
latter interpretation. In both cases, those patients were of
different geographic origin (Turkey vs. Germany and Tur-
key vs. Denmark; see fig. 3). Similarly, for the group of
more frequent mutations, we propose multiple origins for
the geographically most widespread F547L mutation and
also for the geographically more restricted R436W chro-
mosomes, albeit the degree of haplotype diversity differs
between these two mutations. Among the nine recon-
structed F547L chromosomes, three different haplotypes
can be discerned: F547L-A: 288-T-A-G-C-158-158;
F547L-B: 290-T-G-T-T-158-158; and F547L-C: 290/
292-T-A-T-T-158-158 (marker order according to figs.
1a and 3). Haplotype F547L-C includes chromosomes
with either the 290-bp or the 292-bp allele at marker
CNGA3-STR. On the basis of the conservation of the
SNP allele sequence, which occurs at a relative frequency
of 1.2 on control chromosomes ( ), this differencenp 37
at CNGA-STR probably results from a recombination
or a mutation at the STR locus. Since the observed 158-
bp alleles at D2S2311 and D2S2187 represent the pre-
dominant marker alleles (relative frequencies .42 and
.57, respectively, in control chromosomes), the presence
of the same allele sequence (158-158) for these markers
in all F547L haplotypes does not support a common
origin. Interestingly, a common haplotype, F547L-A,
was found on two F547L chromosomes present in Turk-
ish patients as well as on another F547L chromosome
from an Italian patient, consistent with a genetic ex-
change along the Mediterranean coast. Even more sur-
prising, we found a common haplotype, F547L-C,
shared by a German patient and a F547L homozygous
patient originating from Pakistan.
Haplotype reconstruction allowed no convincing con-
clusions about the origin of the P163L and R277C mu-
tations. In both groups, there are deviant haplotypes that
differ from their counterparts only at one flank with
respect to the mutation site (fig. 3). We cannot rule out
an independent origin of these chromosomes; however,
recombination events or mutations at marker loci might
also have led to the deviation from the original haplo-
type. Since the majority of R277C mutant chromosomes
share a common haplotype, 292-T-A-G-C-158-158, it is
reasonable to propose that a founder effect at least con-
tributes to the elevated frequency of this mutation.
In contrast, there is clear evidence for a monophyletic
origin of the I312del mutation, as well as the R427C
mutation. A complete correspondence of haplotypes was
observed for the two I312del chromosomes reconstructed
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Figure 3 Haplotypes of CNGA3 mutant chromosomes. The origins of patients are given in the second column: D p Germany; DK p
Denmark; GR p Greece; HT p Haiti; I p Italy; N p Norway; NL p The Netherlands; PK p Pakistan; S p Sweden; TK p Turkey; and
US p United States. Similar haplotypes for a given mutation (which probably reflect a common origin) are boxed, and deviations within a
group of similar haplotypes are represented by blank haplotype segments. The dark-shaded segment for CHRO180 represent a second-order
haplotype deviation. The vertical line marked by an arrowhead represents the relative position of the mutations, between SNP 215151TrC
and D2S2311. Alleles of STR markers are given as fragment sizes.
in families CHRO13 and CHRO66 and can be also as-
sumed for the R427C chromosomes, for which the phase
at some markers could not be resolved experimentally.
Finally, we suggest a common origin of the R283W
mutation, the most prevalent mutation in CNGA3. Hap-
lotypes of 17 R283W chromosomes were reconstructed
from 11 independent patients. Although parental con-
sanguinity could not be established for the six patients
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with homozygous R283W mutations, all but one were
also homozygous for all tested markers and thus were
considered as bearing a single haplotype identical-by-
descent (IBD). In contrast, the two R283W chromo-
somes segregating in family CHRO214 differ at mark-
er D2S2187. Therefore, we formally considered both
R283W chromosomes segregating in this family as in-
dependent haplotypes. The final sample of R283W
haplotypes used for comparison thus comprises five
chromosomes representing the R283W homozygotes
considered as IBD, the two R283W chromosomes seg-
regating in family CHRO214, and another five R283W
chromosomes from compound-heterozygous patients (fig.
3). Among this sample a common haplotype, 292-T-A-T-
C-158-160, was seen on seven fully resolved R283W
chromosomes and can be traced in three further R283W
chromosomes with incompletely resolved allele assign-
ment (CHRO74, CHRO124, and ZD95). Significantly,
all these chromosomes share the 160-bp allele at marker
D2S2187, which is uncommon in controls (relative fre-
quency .16). The presence of this particular 160-bp allele
on the R283W chromosome in family ACH09-1 suggests
that its deviation from the common haplotype at marker
CNGA3-STR and SNP 102-16ArG results from an in-
tragenic recombination proximal to the mutation. A sec-
ond deviant R283W chromosome was reconstructed in
family CHRO214. Also, in this case, there are several
reasons that favor a differentiation from the common hap-
lotype rather than an independent origin of the R283W
mutation. These include (a) the presence of a 162-bp allele
at the most distal marker D2S2187 being the only dif-
ference from the common R283W haplotype, (b) the fact
that the conserved haplotype segment (CNGA3-STR
through D2S2311) is rare in controls (relative frequency
.03), and (c) the presence of a second R283W chromo-
some segregating in this family, which is unlikely to be
encountered by chance.
In conclusion, these results strongly support the in-
terpretation that all observed R283W chromosomes
share a common origin. Given the unusual geographic
distribution of the R283W mutation, we argue that,
from a common ancestor, two separate founding pop-
ulations have evolved that account for the elevated fre-
quency of the R283W mutation in northern Europe and
northern Italy.
Phenotypes of Patients with CNGA3 Mutations
Screening of a broad spectrum of cone photoreceptor
disorders in the present study demonstrates that CNGA3
mutations are not necessarily correlated with a phenotype
of complete achromatopsia, as described previously, but
can also be present in patients with other cone disorders.
Clinical data were available for 67 patients with CNGA3
mutations (table 2). Thirty-three patients from 26 families
had a diagnosis of complete achromatopsia. Their visual
acuities ranged from 0.05 to 0.16, except that one patient
had a visual acuity of 0.2 in one eye. All patients lacked
cone ERG responses under standard clinical setup and
had no color vision. Photophobia was present in all pa-
tients and nystagmus in ∼90% of the patients. Some of
those without nystagmus at the time of examination had
a history of a transient period of nystagmus during child-
hood. Refractive errors were quite variable, ranging from
6.0 to 13.0, but the majority of patients were hyperopic
(mean spherical equivalent 1.72). There was no evi-
dence for any disease progression after early childhood.
CNGA3 mutations were also found in 18 families com-
prising 20 patients with diagnoses of incomplete achro-
matopsia. The considerable variability in the clinical pre-
sentation among these patients probably reflects the
extent of disturbance of the cone photoreceptor system.
Whereas, in some patients, residual cone function could
be detected only by psychophysical color vision testing,
others showed sizeable cone ERGs and only slightly
impaired color vision (e.g., siblings CHRO21/N and
CHRO21/A). Visual acuities ranged from 0.06 to 0.6 and
were, on average, better than those of complete achro-
mats. Color-vision disturbances were rather nonuniform.
Interestingly, some patients could perform color matches
only for certain regions of the visual spectrum (e.g., re-
sidual blue-yellow discrimination). Not all incomplete
achromats complained about photophobia. Those with
the best preserved cone function had no or only moderate
problems with daylight conditions. As in the group of
complete achromats, hyperopia is the predominant re-
fractive error in patients with incomplete achromatopsia
(mean spherical equivalent 0.541).
The available clinical data for 11 patients did not suf-
fice to categorize them reliably as complete or incomplete
achromats. These cases are therefore presented as non-
classified cases in table 2.
Finally, three patients had a diagnosis of cone dystro-
phy. Current cone photoreceptor function parameters
were similar to those observed in patients with achro-
matopsia, but there was evidence for a progression, either
in follow-up examinations (ZD53/A) or subjectively re-
ported by the patient (ZD82/H) and/or due to the pres-
ence of funduscopic abnormalities (ZD95/K and ZD82/
H). In addition, two of these patients (ZD53/A and ZD95/
K) showed reduced rod function in ERGs.
In most instances, affected siblings or patients with the
same CNGA3 genotype showed a similar clinical phe-
notype. A notable exception were the patients homozy-
gous for the R283W mutation. Some of them were com-
plete achromats with no detectable cone function, where-
as others had residual cone ERG responses and/or color
vision, justifying the diagnosis of incomplete achroma-
topsia (table 2; CHRO214/P and CHRO252/C).
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conditions is principally complicated by the uncertainty,
in compound heterozygotes, about which of the two mu-
tant alleles retains the crucial functional activity, about
whether both mutant alleles act synergistically and about
whether they can complement each other. Despite these
inherent limitations, it is noteworthy that the R427C,
R563H, and T565M mutations have been exclusively
found in patients with incomplete achromatopsia or cone
dystrophy and thus represent the best candidates for mu-
tations that do not completely abolish cone photoreceptor
function. Interestingly, we found that two of the patients
with the least severe visual complaints (CHRO21 and
CHRO119) were both compound heterozygotes for mu-
tations in the cytoplasmic linker between transmembrane
domains S2 and S3 and in the channels’ pore regions
(T224R/T369S and R223W/S341P, respectively).
It has been shown that the murine and bovine ortho-
logues of the human CNGA3 gene are also expressed
in nonretinal tissues, notably kidney, testis, and the pin-
eal gland (Biel et al. 1994). However, none of the patients
with CNGA3 mutations had a positive medical history
for systemic disease and evaluation of self-assessment
patient questionnaires (13 respondents) revealed no ev-
idence that mutations in the CNGA3 gene were asso-
ciated with other, nonvisual illnesses or complaints.
Discussion
We have recently shown that mutations in the CNGA3
gene cause complete achromatopsia (Kohl et al. 1998).
One of the major findings of the present study is that
CNGA3 mutations do not only lead to complete achro-
matopsia but can also cause incomplete achromatopsia
with residual cone function. The phenotypic presentation
of such incomplete achromats is highly variable, ranging
from cases with barely detectable remnants of color vision
to those with well-preserved visual acuity and only slightly
abnormal color vision. Some of the incomplete achromats
with CNGA3 mutations showed residual color-sensitivity
only for parts of the visual spectrum rather than a uniform
defect. This peculiar variability in color sensitivity has
already been noticed in early clinical descriptions of in-
complete achromats (Ja¨ger 1953; Goodman et al. 1963).
We also found that disease expression can vary among
siblings or patients with the same CNGA3 genotype. For
example, on detailed electrophysiological and psycho-
physical investigations, apparent differences in the extent
of cone dysfunction were found between the affected sib-
lings in family CHRO21, who had the least severe visual
complaints of all patients with CNGA3 mutations (H.
Ja¨gle and L. T. Sharpe, unpublished data). The phenotypic
variability in these patients with rather well-preserved
cone function may result from differences in lens density
and macular pigment (Stockman and Sharpe 1999), as
well as from differences in the S- to M- to L-cone ratio
and distribution (Hagstrom et al. 1998; Roorda and Wil-
liams 1999) or the presence of simultaneous alterations
in the pigment genes. Furthermore, some patients ho-
mozygous for the R283W mutations present as complete
achromats, whereas others had some residual cone func-
tion, although at a low level. It is noteworthy that the
latter were young children (3 and 4 years of age at ex-
amination), in contrast to the four R283W homozygotes
diagnosed as complete achromats, all of whom were48
years old. This may indicate that, in R283W homozy-
gotes, there is a loss of the residual cone function during
the patient’s lifetime, resulting in discrepant clinical pre-
sentation depending on the patients’ age at examination.
However, a progressive loss of cone function as a general
mechanism in achromatopsia is unlikely, since the mean
ages (at examination) of complete and incomplete achro-
mats were nearly identical (24.39 years vs. 24.15 years).
Thus, we have to consider that other factors—like the
precise sequence and expression of the channel b-subunit
or the total number of defective cones that are actually
formed in retinal development—determine the actual clin-
ical phenotype in patients with the same genotype. Such
anticipated distortions in the development of cone pho-
toreceptors and the cone mosaic are documented from
the homologous knockout-mouse model (Biel et al. 1999)
and the sparse histological studies of retinae from achro-
mats (Larsen 1921; Harrison et al. 1960; Falls et al. 1965;
Glickstein and Heath 1975).
The definite categorization of patients as complete or
incomplete achromats can be difficult in those cases
with very low cone function and mainly relies on the
sensitivity and reliability of noninvasive clinical and
psychophysical testing. Because of these diagnostic lim-
itations and the fact that complete and incomplete a-
chromatopsia are caused by mutations in the same gene,
both disorders should rather be considered as part of a
continuous clinical spectrum of cone photoreceptor dys-
function. Nevertheless, the availability of genotype data
now reinforces the demand for the development of im-
proved noninvasive clinical tests and their standardi-
zation, to resolve subtle phenotypic differences.
Some patients with CNGA3 mutations had a diag-
nosis of cone dystrophy. These patients tended to be the
ones with the most-severe clinical symptoms among the
group of cone dystrophy patients analyzed in this study
(for a review about the clinical presentation, see the
report by Kellner [1996]). However, since the evidence
for the presence of a progressive retinal dystrophy is
still limited in these cases, further follow-up examina-
tions and the identification of additional affected indi-
viduals will be necessary to confirm these findings.
Heterozygotes for CNGA3 mutations do not com-
plain of any visual problems and their cone photore-
ceptor function is normal (H. Ja¨gle and L. T. Sharpe,
unpublished data), indicating that CNGA3 mutations
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behave in a strictly recessive manner. In patients with
residual cone function, either one or both mutant alleles
gives rise to some functional CNG channel activity, or
the two mutant channels complement each other for
functional activity. Although the assignment of func-
tional activity is hampered by a limited phenotype-ge-
notype correlation, some alleles with mutations in the
pore region (S341P and T369S) or in the cGMP-binding
domain (R563H and T565M) are prime candidates for
encoding such cone CNG channels with some retained
functional activity. Further experimental evidence for
this assumption and the elucidation of the molecular
pathology might be obtained from the analysis of in
vitro–expressed mutant CNG channels.
In the present study, we were able to identify CNGA3
mutations in 53 index patients. Among them, 16 had
apparently homozygous mutations and another 31 car-
ried two heterozygous mutations. True homozygosity in
the former patients and compound heterozygosity in the
latter could be established in all cases in which additional
samples from family members were available for segre-
gation analysis (12/16 and 23/31, respectively). For the
remainder, we cannot formally exclude other scenarios
(e.g., heterozygous deletions or presence of mutations in
cis). Merely single heterozygous mutations were found
in six additional patients. The simplest explanation for
these cases is that we failed to detect the second muta-
tion—which may be located in as yet unidentified reg-
ulatory domains of the CNGA3 gene—or that some dis-
ease alleles constitute larger deletions that have not been
ruled out in all cases. A dominant effect of these muta-
tions can be excluded in most cases. Three of these pa-
tients (CHRO180/T, CHRO16/G, and CHRO155/M;
see table 2) carry known mutations that were also found
in patients with compound-heterozygous mutations. For
two further patients (CHRO7/P and CHRO208/K) there
were also unaffected family members who possess the
corresponding mutant allele.
Only ∼25% of patients with achromatopsia carry
mutations in the CNGA3 gene. Recently, a second locus
for achromatopsia (ACHM3) has been localized on
chromosome 8q21 (Milunsky et al. 1999; Winick et al.
1999), and, subsequently, we and others have shown
that mutations in the CNGB3 gene encoding the b-
subunit of the cone cGMP-gated channel are responsible
for achromatopsia in patients who show linkage to this
locus (Kohl et al. 2000; Sundin et al. 2000). Preliminary
data indicate that mutations in the CNGB3 gene are
more prevalent in achromats than are those in the
CNGA3 gene (B. Wissinger and S. Kohl, unpublished
data).
Contrary to the expectations for a recessively inherited
disorder, the vast majority of mutations in the CNGA3
gene represent missense mutations. This indicates that
there is little tolerance for substitutions with respect to
functional maintenance of the channel polypeptide. This
notion is supported by the high degree of evolution-
ary conservation not only for CNGA3 orthologues in
different species but also for functional paralogues in
the vertebrate rod photoreceptor and olfactory epithe-
lium and sensory CNG channels in Drosophila and
Caenorhabditis.
Although the majority of mutations are located in
structurally and functionally important parts of the
CNGA3 polypeptide (i.e., the transmembrane helices,
the pore, and the cGMP-binding domain), we observed
a considerable number of missense mutations in less-
well-characterized parts of the protein—in particular,
the linking segments between S1 and S2 and between
S6 and the cGMP-binding domain. The functional con-
tribution of these parts of the protein and the kind of
defect resulting from mutations therein remains to be
established by further functional analysis and biophys-
ical characterization of the CNGA3 channel.
Most CNGA3 mutations were observed only once,
either in the heterozygous state or in the homozygous
state in cases with known or suspected parental con-
sanguinity. However, a few mutations—in particular,
R283W, F547L, R277C, and R436W—were found re-
currently in several independent patients and accounted
for a substantial portion of all mutant alleles. Haplotype
analysis suggests that the F547L mutation has multiple
origins, whereas the R427C chromosomes, as well as
the R283W chromosomes, are genetically related and
probably originate from a common ancestral mutation.
Interestingly, we found the R283W mutation to be most
prevalent among patients from Scandinavia and north-
ern Italy. Since both regional groups share a common
haplotype, there must have been a genetic interchange
in the past between these distant regions, followed by
a regional spreading of this particular disease allele.
We have presented a first comprehensive screening
analysis of CNGA3 in patients with cone photoreceptor
disorders. Although this study now provides the first
data set on the prevalence of CNGA3 mutations and
the associated spectrum of phenotypes, additional func-
tional studies analyzing their pathophysiological effects
on the cone CNG channel, the phototransduction cas-
cade, and retinal development will be necessary to de-
cipher the molecular pathology of cone photoreceptor
disorders caused by CNGA3 mutations.
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